img
img
GENE REPLACEMENT FOR THE PREVENTION OF INHERITED MITOCHONDRIAL DISEASES: THREE-PARENT BABIES AND ETHICS    
Yazarlar (4)
Simge Evrenol Öçal
İzmir Katip Çelebi Üniversitesi, Türkiye
Doç. Dr. Şahika ŞİMŞEK ÇETİNKAYA Doç. Dr. Şahika ŞİMŞEK ÇETİNKAYA
Kastamonu Üniversitesi, Türkiye
Gülten Koç
Hacettepe Üniversitesi, Türkiye
Çiğdem Yücel
Hacettepe Üniversitesi, Türkiye
Devamını Göster
Özet
Mitochondrial diseases increase mortality and morbidity caused by mutations in mitochondrial DNA (mtDNA) or functional gene disorders of mitochondria. Hereditary mutations in mtDNA are an important cause of genetic diseases for which there is no effective treatment and are transmitted from generation to generation. Mutations in DNA have an important role in infertility or other reproductive anomalies that occur later in life by affecting oocyte functions as well as negatively affecting vital organs. With the development of technology, one of the new treatment approaches developed for mitochondrial diseases is mitochondrial gene replacement therapy (MRT). MRT allows women who are carriers of mtDNA mutations to have a genetically healthy child. In this review, MRT, its effects, nursing dimensions, and ethical relationship are discussed.
Anahtar Kelimeler
Bildiri Türü Tebliğ/Bildiri
Bildiri Alt Türü Özet Metin Olarak Yayınlanan Tebliğ (Uluslararası Kongre/Sempozyum)
Bildiri Niteliği Alanında Hakemli Uluslararası Kongre/Sempozyum
Bildiri Dili İngilizce
Kongre Adı International Conference on Nursing Lara,Antalya 16-18 March 2017
Kongre Tarihi 16-03-2017 / 18-03-2017
Basıldığı Ülke Türkiye
Basıldığı Şehir Antalya
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları

Paylaş